Gibco™ DMEM/F-12 CTS™ KnockOut™

Ref.: BL-RE-078129Manufacturer ref.: A1370801 500 ml
€67.50 excl. VAT

The KnockOut™ DMEM ⁄ F-12 CTS™ Cell Therapy Systems is a serum-free medium with low osmolality without HEPES or L-glutamine buffer, optimized for human embryonic stem cell (CSE) and stem cell growth.

Content and storage
Store between 2 and 8°C and shelter from light.
Cell type
Stem cells (embryonic), stem cells (iPS - induced pluripotent strains)
Classification
Animal origin-free
Shape
Liquid
Product type
Media DMEM ⁄ F-12 CTS KnockOut
Brand
Gibco

The KnockOut™ DMEM ⁄ F-12 CTS™ Cell Therapy Systems is a serum-free medium with low osmolality without HEPES or L-glutamine buffer, optimized for human embryonic stem cell (CSE) and stem cell growth.

KnockOut™ DMEM ⁄ F-12 CTS™ Cell Therapy Systems is a serum-free medium with low osmolality without HEPES or L-glutamine buffer, optimized for human embryonic stem cell (CSE) and induced pluripotent stem cells (CSPi). The KnockOut™ DMEM/F-12 CTS™ medium is designed to be used with KnockOut™ SR and KnockOut™ SR XenoFree supplements.

Designed for reliable and consistent performance

Perform a CSE/CSPi culture with little or no spontaneous differentiation Be ready for clinical research with this formula manufactured by the BPFa and the assistance documentation

Coherent results without fetal calf serum

The KnockOut™ DMEM/F-12 CTS™ Cell Therapy Systems media are part of the KnockOut™ media product range that has provided reliable results for the ESC and has maintained iPSC culture for years. This foetal-free medium causes little or no spontaneous differentiation, and frees you from repeated selections.

Equivalent morphology

Stem cells grown in KnockOut™ DMEM/F-12 CTS™ media exhibit normal morphology and karyotype compared to control stem cells. You can also expect a morphology equivalent to manual-pass HES, even after an enzymatic passage.

Simplify your transition to clinical research

The brand Gibco™ Cell Therapy Systems (CTS™) offers a wide range of products for use in cell therapy applications, including media, reagents, growth factors, enzymes, cell selection/expansion reagents and devices. Gibco™ Cell Therapy Systems (CTS™) products offer: reduced workload related to qualifying reagents, Included are appropriate certificates of analysis and origin Practical access to our master drug file (DMF)

Perform a CSE/CSPi culture with little or no...

Perform a CSE/CSPi culture with little or no spontaneous differentiation

Be ready for clinical research thanks to...

Get ready for clinical research with this formula made by the BPFa and support documentation Coherent results without fetal calf serum KnockOut™ DMEM/F-12 CTS™ Cell Therapy Systems...

Reducing workload related to...

Reduction in the workload associated with qualifying reagents,

Certificates of analysis and...

Appropriate certificates of analysis and origin are included.

Technical specifications

General
BrandGibco
Supplier ref. (Fisher Scientific)12023479
Specifications
Cell typeStem cells (embryonic), stem cells (iPS - induced pluripotent strains)
ClassificationAnimal origin-free
ShapeLiquid
Product typeMedia DMEM ⁄ F-12 CTS KnockOut
FormatBottle
For use with (application)Cell and Gene Therapy Research, Development, and Manufacturing
Ecological conceptDurable packaging
Manufacturing qualityBPFa for medical devices, 21 CFR Part 820 and ISO 13485
Quantity500 ml
Compliance
SterilitySterile filtration
Storage and shipping
Content and storageStore between 2 and 8°C and shelter from light.
Shipping conditionsAmbient temperature

Origin and customs

Manufacturer ref.A1370801
Country of originUnited States
HS customs code3821 00 00 00
A question or a specific configuration?
Contact us for a quote.